發送短信 : Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

  _  __   _    _     _  __     ___     _____    
 | |/ // | || | ||  | |/ //   / _ \\  |  __ \\  
 | ' //  | || | ||  | ' //   / //\ \\ | |  \ || 
 | . \\  | \\_/ ||  | . \\  |  ___  ||| |__/ || 
 |_|\_\\  \____//   |_|\_\\ |_||  |_|||_____//  
 `-` --`   `---`    `-` --` `-`   `-`  -----`